All articles tagged with #vision preservation
Scientists discovered that in retinitis pigmentosa, the retina can adapt by rerouting signals from cones to rod bipolar cells, helping preserve daylight vision longer despite rod loss, which could inform future treatments.
A new study demonstrates that the ENCELTO implant, which releases a protective protein in the eye, can slow vision loss in patients with macular telangiectasia type 2, potentially leading to FDA approval and offering a long-term treatment option for this degenerative retinal disease.
Research shows that retinal neurons can rewire themselves to maintain vision in retinitis pigmentosa, with rod bipolar cells forming new connections with cone cells as rods degenerate, a process triggered by degeneration itself and not just light response loss, offering potential targets for therapies to slow vision loss.